制酸薬の世界市場2019-2023

◆英語タイトル:Global Antacids Market 2019-2023
◆商品コード:IRTNTR30359
◆発行会社(リサーチ会社):Technavio
◆発行日:2018年12月3日
◆ページ数:111
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル、アジア、北米、ヨーロッパ(EMEA)
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥267,500見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥321,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥428,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、制酸薬の世界市場について調査・分析し、市場概要、市場環境、制酸薬市場規模、種類別(全身用、全身用以外)分析、市場動向、競争環境、主要地域別市場規模(北米、ヨーロッパ、アジアなど)、関連企業情報などを含め、以下の構成でお届け致します。
・エグゼクティブサマリー
・調査範囲・調査手法
・制酸薬の世界市場概要
・制酸薬の世界市場環境
・制酸薬の世界市場動向
・制酸薬の世界市場規模
・制酸薬の世界市場:業界構造分析
・制酸薬の世界市場:種類別(全身用、全身用以外)
・制酸薬の世界市場:地域別市場規模・分析
・制酸薬の北米市場規模・予測
・制酸薬のヨーロッパ・中東・アフリカ市場規模・予測
・制酸薬のアジア太平洋市場規模・予測
・制酸薬の主要国分析
・制酸薬の世界市場:意思決定フレームワーク
・制酸薬の世界市場:成長要因、課題
・制酸薬の世界市場:競争環境
・制酸薬の世界市場:関連企業情報(ベンダー分析)

主な分析対象企業は、Bayer、GlaxoSmithKline、Johnson & Johnson Services、Novartis、Sanofiなどです。
【レポートの概要】

About this market
The global antacids market sees an increasing trend of online transactions as the market is dominated by OTC drugs that require no prescription. It is easy for the consumption to shop online without requiring prior extensive product knowledge. The major reason for the increased popularity of e- commerce retailing has been the retailer’s efforts on improving the online shopping experience through better online education and targeted marketing. This increases the comfort level of consumers buying a product online. Therefore, several organizations have come up to tap this market potential, thereby fueling market growth.
Market Overview
Increasing use of NSAIDs
NSAIDS have been used for many years for the treatment of arthritis and inflammation and protection from cardiovascular. NSAIDs is expected to increase with the increasing aging population and potential news indications. Therefore, NSAIDs are associated with several gastric problems, including dyspeptic symptoms and the development of gastric ulceration.
Counterfeit drugs
The probability of buying counterfeit drugs in the global antacids market is high as the market is dominated by generics and OTC drugs. The consumption of counterfeit drugs can affect the health of the consumer, and their availability in the market can affect the sales of branded drugs.
For the detailed list of factors that will drive and challenge the growth of the antacids market during the 2019-2023, view our report.
Competitive Landscape
The antacids market is fragmented owing to the presence of several established and regional vendors. This antacids industry research report focuses on the competitive landscape and lists the various products and services offered by the leading companies. The global antacids market analysis report will also help clients in gauging the market competition and identifying new growth opportunities.

【レポートの目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY TYPE
PART 07: CUSTOMER LANDSCAPE
• Market segmentation by type
• Comparison by type
• Non-systemic antacids – Market size and forecast 2018-2023
• Systemic antacids – Market size and forecast 2018-2023
• Market opportunity by type
PART 08: CUSTOMER LANDSCAPE
PART 09: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• Americas – Market size and forecast 2018-2023
• EMEA – Market size and forecast 2018-2023
• APAC – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
• PART 11: MARKET TRENDS
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Bayer
• GlaxoSmithKline
• Johnson & Johnson Services
• Novartis
• Sanofi
PART 14: APPENDIX
• Research methodology
• List of abbreviations


Exhibit 01: Years in consideration
Exhibit 02: Global GERD market
Exhibit 03: Segments of global GERD market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2018
Exhibit 18: Type – Market share 2018-2023 (%)
Exhibit 19: Comparison by type
Exhibit 20: Non-systemic antacids – Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Non-systemic antacids – Year-over-year growth 2019-2023 (%)
Exhibit 22: Systemic antacids – Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Systemic antacids – Year-over-year growth 2019-2023 (%)
Exhibit 24: Market opportunity by type
Exhibit 25: Market share by geography 2018-2023 (%)
Exhibit 26: Geographic comparison
Exhibit 27: Americas – Market size and forecast 2018-2023 ($ millions)
Exhibit 28: Americas – Year-over-year growth 2019-2023 (%)
Exhibit 29: EMEA – Market size and forecast 2018-2023 ($ millions)
Exhibit 30: EMEA – Year-over-year growth 2019-2023 (%)
Exhibit 31: APAC – Market size and forecast 2018-2023 ($ millions)
Exhibit 32: APAC – Year-over-year growth 2019-2023 (%)
Exhibit 33: Key leading countries
Exhibit 34: Market opportunity
Exhibit 35: Decision framework
Exhibit 36: Global prevalence of geriatric population
Exhibit 37: Impact of drivers and challenges
Exhibit 38: Drugs that underwent prescription to OTC switch in US
Exhibit 39: Vendor landscape
Exhibit 40: Landscape disruption
Exhibit 41: Vendors covered
Exhibit 42: Vendor classification
Exhibit 43: Market positioning of vendors
Exhibit 44: Bayer – Vendor overview
Exhibit 45: Bayer – Business segments
Exhibit 46: Bayer – Organizational developments
Exhibit 47: Bayer – Geographic focus
Exhibit 48: Bayer – Segment focus
Exhibit 49: Bayer – Key offerings
Exhibit 50: Bayer – Key customers
Exhibit 51: GlaxoSmithKline – Vendor overview
Exhibit 52: GlaxoSmithKline – Business segments
Exhibit 53: GlaxoSmithKline – Organizational developments
Exhibit 54: GlaxoSmithKline – Geographic focus
Exhibit 55: GlaxoSmithKline – Segment focus
Exhibit 56: GlaxoSmithKline – Key offerings
Exhibit 57: GlaxoSmithKline – Key customers
Exhibit 58: Johnson & Johnson Services – Vendor overview
Exhibit 59: Johnson & Johnson Services – Business segments
Exhibit 60: Johnson & Johnson Services – Organizational developments
Exhibit 61: Johnson & Johnson Services – Geographic focus
Exhibit 62: Johnson & Johnson Services – Segment focus
Exhibit 63: Johnson & Johnson Services – Key offerings
Exhibit 64: Johnson & Johnson Services – Key customers
Exhibit 65: Novartis – Vendor overview
Exhibit 66: Novartis – Business segments
Exhibit 67: Novartis – Organizational developments
Exhibit 68: Novartis – Geographic focus
Exhibit 69: Novartis – Segment focus
Exhibit 70: Novartis – Key offerings
Exhibit 71: Novartis – Key customers
Exhibit 72: Sanofi – Vendor overview
Exhibit 73: Sanofi – Business segments
Exhibit 74: Sanofi – Organizational developments
Exhibit 75: Sanofi – Geographic focus
Exhibit 76: Sanofi – Segment focus
Exhibit 77: Sanofi – Key offerings
Exhibit 78: Sanofi – Key customers
Exhibit 79: Validation techniques employed for market sizing
Exhibit 80: List of abbreviations



【掲載企業】

Bayer、GlaxoSmithKline、Johnson & Johnson Services、Novartis、Sanofi

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[制酸薬の世界市場2019-2023]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆